Virtus ETF Advisers LLC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 59 filers reported holding ARCUS BIOSCIENCES INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q2 2024$81,100
-12.5%
5,325
+8.4%
0.04%
-18.4%
Q1 2024$92,720
-7.6%
4,911
-6.5%
0.05%
-23.4%
Q4 2023$100,294
+10.8%
5,251
+4.1%
0.06%
+16.4%
Q3 2023$90,504
-19.7%
5,042
-9.1%
0.06%
-17.9%
Q2 2023$112,680
+105.2%
5,548
+84.3%
0.07%
+123.3%
Q1 2023$54,902
-36.3%
3,010
-27.7%
0.03%
-33.3%
Q4 2022$86,153
-35.2%
4,166
-17.8%
0.04%
-15.1%
Q3 2022$133,000
+4.7%
5,068
+0.8%
0.05%
+12.8%
Q2 2022$127,000
+1.6%
5,029
+27.2%
0.05%
-16.1%
Q1 2022$125,000
-26.0%
3,954
-5.4%
0.06%
-12.5%
Q4 2021$169,000
-44.0%
4,179
-51.8%
0.06%
-51.9%
Q3 2021$302,000
+20.8%
8,664
-4.9%
0.13%
+29.1%
Q2 2021$250,000
-4.6%
9,111
-2.5%
0.10%
-7.2%
Q1 2021$262,000
+9.6%
9,348
+1.7%
0.11%
+12.1%
Q4 2020$239,000
+25.8%
9,188
-17.0%
0.10%
-1.0%
Q3 2020$190,000
-39.1%
11,075
-12.1%
0.10%
-32.4%
Q2 2020$312,000
-22.0%
12,599
-56.1%
0.15%
+261.0%
Q3 2018$400,000
-34.3%
28,669
-42.4%
0.04%
-92.4%
Q2 2018$609,00049,7340.54%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q3 2018
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$29,404,28419.15%
Decheng Capital Management III (Cayman), LLC 869,790$15,864,9706.40%
Octagon Capital Advisors LP 2,172,000$39,617,2805.70%
Boxer Capital, LLC 1,432,200$26,1231.28%
PFM Health Sciences, LP 1,559,947$28,453,4331.26%
SECTORAL ASSET MANAGEMENT INC 293,646$5,356,1031.03%
DAFNA Capital Management LLC 175,217$3,195,9580.96%
Ikarian Capital, LLC 230,000$4,195,2000.95%
Tejara Capital Ltd 50,000$912,0000.47%
Capital Impact Advisors, LLC 20,501$373,9380.46%
View complete list of ARCUS BIOSCIENCES INC shareholders